12-Month results of the standardised combination therapy for diabetic macular oedema: Intravitreal bevacizumab and navigated retinal photocoagulation

Giulio Barteselli, Igor Kozak, Sharif El-Emam, Jay Chhablani, Marco A. Cortes, William R. Freeman

Research output: Contribution to journalArticle

Abstract

Aim: To evaluate the efficacy of a standardised combination therapy for clinically significant diabetic macular oedema using bevacizumab injections followed by navigated laser photocoagulation to stabilise retinal thickness. Methods: In this pilot study we retrospectively reviewed charts and imaging of 23 eyes treated with the standardised combination regimen. Eyes initially received monthly bevacizumab injections, followed by navigated laser photocoagulation when central retinal thickness (CRT) was

Original languageEnglish
Pages (from-to)1036-1041
Number of pages6
JournalBritish Journal of Ophthalmology
Volume98
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Macular Edema
Light Coagulation
Lasers
Injections
Therapeutics
Bevacizumab

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

12-Month results of the standardised combination therapy for diabetic macular oedema : Intravitreal bevacizumab and navigated retinal photocoagulation. / Barteselli, Giulio; Kozak, Igor; El-Emam, Sharif; Chhablani, Jay; Cortes, Marco A.; Freeman, William R.

In: British Journal of Ophthalmology, Vol. 98, No. 8, 2014, p. 1036-1041.

Research output: Contribution to journalArticle

Barteselli, Giulio ; Kozak, Igor ; El-Emam, Sharif ; Chhablani, Jay ; Cortes, Marco A. ; Freeman, William R. / 12-Month results of the standardised combination therapy for diabetic macular oedema : Intravitreal bevacizumab and navigated retinal photocoagulation. In: British Journal of Ophthalmology. 2014 ; Vol. 98, No. 8. pp. 1036-1041.
@article{19508b7f9c254809ac3d3e6c228dc1fc,
title = "12-Month results of the standardised combination therapy for diabetic macular oedema: Intravitreal bevacizumab and navigated retinal photocoagulation",
abstract = "Aim: To evaluate the efficacy of a standardised combination therapy for clinically significant diabetic macular oedema using bevacizumab injections followed by navigated laser photocoagulation to stabilise retinal thickness. Methods: In this pilot study we retrospectively reviewed charts and imaging of 23 eyes treated with the standardised combination regimen. Eyes initially received monthly bevacizumab injections, followed by navigated laser photocoagulation when central retinal thickness (CRT) was",
author = "Giulio Barteselli and Igor Kozak and Sharif El-Emam and Jay Chhablani and Cortes, {Marco A.} and Freeman, {William R.}",
year = "2014",
doi = "10.1136/bjophthalmol-2013-304488",
language = "English",
volume = "98",
pages = "1036--1041",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - 12-Month results of the standardised combination therapy for diabetic macular oedema

T2 - Intravitreal bevacizumab and navigated retinal photocoagulation

AU - Barteselli, Giulio

AU - Kozak, Igor

AU - El-Emam, Sharif

AU - Chhablani, Jay

AU - Cortes, Marco A.

AU - Freeman, William R.

PY - 2014

Y1 - 2014

N2 - Aim: To evaluate the efficacy of a standardised combination therapy for clinically significant diabetic macular oedema using bevacizumab injections followed by navigated laser photocoagulation to stabilise retinal thickness. Methods: In this pilot study we retrospectively reviewed charts and imaging of 23 eyes treated with the standardised combination regimen. Eyes initially received monthly bevacizumab injections, followed by navigated laser photocoagulation when central retinal thickness (CRT) was

AB - Aim: To evaluate the efficacy of a standardised combination therapy for clinically significant diabetic macular oedema using bevacizumab injections followed by navigated laser photocoagulation to stabilise retinal thickness. Methods: In this pilot study we retrospectively reviewed charts and imaging of 23 eyes treated with the standardised combination regimen. Eyes initially received monthly bevacizumab injections, followed by navigated laser photocoagulation when central retinal thickness (CRT) was

UR - http://www.scopus.com/inward/record.url?scp=84905106647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905106647&partnerID=8YFLogxK

U2 - 10.1136/bjophthalmol-2013-304488

DO - 10.1136/bjophthalmol-2013-304488

M3 - Article

C2 - 24723616

AN - SCOPUS:84905106647

VL - 98

SP - 1036

EP - 1041

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 8

ER -